User profiles for Filip Scheperjans

Filip Scheperjans

Dept. of Neurology, Helsinki University Hospital
Verified email at hus.fi
Cited by 7481

Gut microbiota are related to Parkinson's disease and clinical phenotype

F Scheperjans, V Aho, PAB Pereira… - Movement …, 2015 - Wiley Online Library
In the course of Parkinson's disease (PD), the enteric nervous system (ENS) and parasympathetic
nerves are amongst the structures earliest and most frequently affected by alpha‐…

The human inferior parietal lobule in stereotaxic space

S Caspers, SB Eickhoff, S Geyer, F Scheperjans… - Brain Structure and …, 2008 - Springer
Recently, a new cytoarchitectonic map of the human inferior parietal lobule (IPL) has been
proposed, with the IPL consisting of seven cytoarchitectonically distinct areas (Caspers et al. …

[HTML][HTML] Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease

…, P Auvinen, MG Tansey, F Scheperjans - Molecular …, 2021 - Springer
Background Previous studies have reported that gut microbiota, permeability, short-chain
fatty acids (SCFAs), and inflammation are altered in Parkinson’s disease (PD), but how these …

Probabilistic maps, morphometry, and variability of cytoarchitectonic areas in the human superior parietal cortex

F Scheperjans, SB Eickhoff, L Hömke… - Cerebral …, 2008 - academic.oup.com
Recently, 8 areas (5Ci, 5M, 5L, 7PC, 7A, 7P, 7M, hIP3) in the human superior parietal cortex
(SPC) were delineated in 10 postmortem brains using observer-independent …

Observer-independent cytoarchitectonic mapping of the human superior parietal cortex

F Scheperjans, K Hermann, SB Eickhoff… - Cerebral …, 2008 - academic.oup.com
The human superior parietal cortex (SPC; Brodmann areas [BA] 5 and 7) comprises the
superior parietal lobule and medial wall of the intraparietal sulcus (mIPS) laterally and the …

[HTML][HTML] Gut microbiota in Parkinson's disease: temporal stability and relations to disease progression

…, L Paulin, E Pekkonen, P Auvinen, F Scheperjans - …, 2019 - thelancet.com
Background Several publications have described differences in cross-sectional comparisons
of gut microbiota between patients with Parkinson's disease and control subjects, with …

Oral and nasal microbiota in Parkinson's disease

…, E Pekkonen, P Auvinen, F Scheperjans - Parkinsonism & related …, 2017 - Elsevier
Introduction Parkinson's disease (PD) is associated with neuropathological changes in
olfactory and gastrointestinal tissues, and PD patients frequently suffer from hyposmia, …

[HTML][HTML] Increasing comparability and utility of gut microbiome studies in Parkinson's disease: a systematic review

…, PAB Pereira, VTE Aho, F Scheperjans - Journal of …, 2019 - content.iospress.com
Gut microbiota have been studied in relation to the pathophysiology of Parkinson’s disease (PD)
due to the early gastrointestinal symptomatology and presence of alpha-synuclein …

[HTML][HTML] The gut and Parkinson's disease: hype or hope?

F Scheperjans, P Derkinderen… - Journal of Parkinson's …, 2018 - content.iospress.com
In the last two decades it has become clear that Parkinson’s disease (PD) is associated with
a plethora of gastrointestinal symptoms originating from functional and structural changes in …

Intraputamenal cerebral dopamine neurotrophic factor in Parkinson's disease: a randomized, double‐blind, multicenter phase 1 trial

…, P Almqvist, A Varrone, F Scheperjans… - Movement …, 2023 - Wiley Online Library
Background Cerebral dopamine neurotrophic factor (CDNF) is an unconventional neurotrophic
factor that protects dopamine neurons and improves motor function in animal models of …